İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2015

Efficacy of nitric oxide with or without continuing antihypertensive treatment for management of high blood pressure in acute stroke ENOS a partial factorial randomised controlled trial

Dergi

LANCET

ISSN 0140-6736

ISSN kaydı başka bir dergiye işaret ediyor; ad YÖKSİS kaydından.

YÖKSİS OpenAlex Açık erişim · hybrid SJR Q1 JCR Q1 Atıf 331 Üst %1 Yüzdelik 99.7% FWCI 19.66
Yıl
2015
Tür
article

Veri kaynağı ayrımı

  • YÖKSİS YÖKSİS makale kaydı
  • YÖKSİS dergi adı LANCET
  • Katalog eşleşmesi (ISSN) The Lancet
  • OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

OpenAlex · İngilizce

BACKGROUND: High blood pressure is associated with poor outcome after stroke. Whether blood pressure should be lowered early after stroke, and whether to continue or temporarily withdraw existing antihypertensive drugs, is not known. We assessed outcomes after stroke in patients given drugs to lower their blood pressure. METHODS: In our multicentre, partial-factorial trial, we randomly assigned patients admitted to hospital with an acute ischaemic or haemorrhagic stroke and raised systolic blood pressure (systolic 140-220 mm Hg) to 7 days of transdermal glyceryl trinitrate (5 mg per day), started within 48 h of stroke onset, or to no glyceryl trinitrate (control group). A subset of patients who were taking antihypertensive drugs before their stroke were also randomly assigned to continue or stop taking these drugs. The primary outcome was function, assessed with the modified Rankin Scale at 90 days by observers masked to treatment assignment. This study is registered, number ISRCTN99414122. FINDINGS: Between July 20, 2001, and Oct 14, 2013, we enrolled 4011 patients. Mean blood pressure was 167 (SD 19) mm Hg/90 (13) mm Hg at baseline (median 26 h [16-37] after stroke onset), and was significantly reduced on day 1 in 2000 patients allocated to glyceryl trinitrate compared with 2011 controls (difference -7·0 [95% CI -8·5 to -5·6] mm Hg/-3·5 [-4·4 to -2·6] mm Hg; both p<0·0001), and on day 7 in 1053 patients allocated to continue antihypertensive drugs compared with 1044 patients randomised to stop them (difference -9·5 [95% CI -11·8 to -7·2] mm Hg/-5·0 [-6·4 to -3·7] mm Hg; both p<0·0001). Functional outcome at day 90 did not differ in either treatment comparison-the adjusted common odds ratio (OR) for worse outcome with glyceryl trinitrate versus no glyceryl trinitrate was 1·01 (95% CI 0·91-1·13; p=0·83), and with continue versus stop antihypertensive drugs OR was 1·05 (0·90-1·22; p=0·55). INTERPRETATION: In patients with acute stroke and high blood pressure, transdermal glyceryl trinitrate lowered blood pressure and had acceptable safety but did not improve functional outcome. We show no evidence to support continuing prestroke antihypertensive drugs in patients in the first few days after acute stroke. FUNDING: UK Medical Research Council.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

331 atıf

OpenAlex cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 15 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial 2018 Atıf 489 · OpenAlex
  2. Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial 2017 Atıf 184 · OpenAlex
  3. Glyceryl Trinitrate for Acute Intracerebral Hemorrhage Results From the Efficacy of Nitric Oxide in Stroke ENOS Trial a Subgroup Analysis 2016 Atıf 44 · OpenAlex
  4. Infections Up to 76 Days After Stroke Increase Disability and Death 2017 Atıf 37 · OpenAlex
  5. A database for screening and registering Late Onset Pompe Disease in Turkey 2018 Atıf 26 · OpenAlex
  6. Relationship between race and outcome in Asian, Black, and Caucasian patients with spontaneous intracerebral hemorrhage: Data from the Virtual International Stroke Trials Archive and Efficacy of Nitric Oxide in Stroke trial. 2017 Atıf 26 · OpenAlex
  7. Route of Feeding as a Proxy for Dysphagia After Stroke and the Effect of Transdermal Glyceryl Trinitrate: Data from the Efficacy of Nitric Oxide in Stroke Randomised Controlled Trial 2018 Atıf 17 · OpenAlex
  8. Route of Feeding as a Proxy for Dysphagia After Stroke and the Effect of Transdermal Glyceryl Trinitrate: Data from the Efficacy of Nitric Oxide in Stroke Randomised Controlle 2017 Atıf 17 · OpenAlex
  9. Continuing versus Stopping Prestroke Antihypertensive Therapy in Acute Intracerebral Hemorrhage: A Subgroup Analysis of the Efficacy of Nitric Oxide in Stroke Trial 2016 Atıf 14 · OpenAlex
  10. Effect of continuing versus stopping pre-stroke antihypertensive agents within 12 h on outcome after stroke: A subgroup analysis of the efficacy of nitric oxide in stroke (ENOS) trial 2022 Atıf 8 · OpenAlex

Yazarlar

  1. PM BATH
  2. L WOODHOUSE
  3. P SCUTT
  4. K KRISHNAN
  5. JM WARDLAW
  6. D BERECZKI
  7. N SPRIGG
  8. E BERGE
  9. M BERIDZE
  10. V CASO
  11. C CHEN
  12. H CHRISTENSEN
  13. R COLLINS
  14. A EL ETRIBI
  15. AC LASKA
  16. KR LEES
  17. ŞEREFNUR ÖZTÜRK SELÇUK ÜNİVERSİTESİ
  18. S PHILLIPS
  19. S POCOCK
  20. HA DE SILVA
  21. S SZATMARI
  22. S UTTON